Encompass Health Co. (NYSE:EHC) Shares Acquired by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. increased its stake in Encompass Health Co. (NYSE:EHC - Free Report) by 0.7% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 644,764 shares of the company's stock after buying an additional 4,345 shares during the quarter. Charles Schwab Investment Management Inc. owned about 0.64% of Encompass Health worth $59,544,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of EHC. TD Private Client Wealth LLC grew its position in shares of Encompass Health by 2,870.0% in the 3rd quarter. TD Private Client Wealth LLC now owns 7,336 shares of the company's stock worth $709,000 after acquiring an additional 7,089 shares in the last quarter. Pathstone Holdings LLC grew its position in shares of Encompass Health by 54.5% in the 3rd quarter. Pathstone Holdings LLC now owns 21,022 shares of the company's stock worth $2,032,000 after acquiring an additional 7,412 shares in the last quarter. Meeder Asset Management Inc. grew its position in shares of Encompass Health by 43.8% in the 3rd quarter. Meeder Asset Management Inc. now owns 66,405 shares of the company's stock worth $6,417,000 after acquiring an additional 20,242 shares in the last quarter. Geode Capital Management LLC grew its position in shares of Encompass Health by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 1,673,610 shares of the company's stock worth $161,781,000 after acquiring an additional 20,547 shares in the last quarter. Finally, Central Pacific Bank Trust Division grew its position in shares of Encompass Health by 15.1% in the 4th quarter. Central Pacific Bank Trust Division now owns 3,195 shares of the company's stock worth $295,000 after acquiring an additional 418 shares in the last quarter. Institutional investors and hedge funds own 97.25% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on EHC shares. Royal Bank of Canada reiterated an "outperform" rating and issued a $110.00 target price on shares of Encompass Health in a research report on Tuesday, February 11th. William Blair reaffirmed an "outperform" rating on shares of Encompass Health in a research note on Friday, February 7th. StockNews.com raised Encompass Health from a "hold" rating to a "buy" rating in a research note on Saturday, February 15th. Barclays upped their price objective on Encompass Health from $116.00 to $118.00 and gave the company an "overweight" rating in a report on Friday, February 7th. Finally, KeyCorp upped their price objective on Encompass Health from $117.00 to $120.00 and gave the company an "overweight" rating in a report on Monday, February 10th. Ten investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus price target of $107.67.

Remove Ads

Encompass Health Stock Down 2.9 %

Shares of EHC opened at $94.18 on Thursday. Encompass Health Co. has a one year low of $74.27 and a one year high of $104.55. The company has a market cap of $9.48 billion, a P/E ratio of 21.12, a P/E/G ratio of 2.31 and a beta of 0.92. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04. The firm has a 50 day simple moving average of $97.22 and a two-hundred day simple moving average of $96.88.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings data on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. Research analysts forecast that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be paid a $0.17 dividend. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.68 annualized dividend and a yield of 0.72%. Encompass Health's dividend payout ratio (DPR) is 15.25%.

Insider Transactions at Encompass Health

In other news, CAO Andrew L. Price sold 5,042 shares of Encompass Health stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the completion of the sale, the chief accounting officer now directly owns 69,164 shares of the company's stock, valued at approximately $6,798,129.56. The trade was a 6.79 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 2.10% of the stock is currently owned by company insiders.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.